Comparison of SynCardia total artificial heart and HeartWare HVAD biventricular support for management of biventricular heart failure: a systematic review and meta-analysis.
Publication/Presentation Date
3-1-2020
Abstract
BACKGROUND: The aim of this study was to compare the outcomes of patients undergoing SynCardia total artificial heart (TAH) and biventricular HeartWare ventricular assist device (Bi-HVAD) support for biventricular heart failure (HF).
METHODS: Electronic search was performed to identify all relevant studies detailing patients who underwent biventricular assist device implantation using Bi-HVAD devices and those who underwent TAH placement for biventricular HF. Twelve studies including 512 patients in the TAH group versus 38 patients in the Bi-HVAD group were pooled for meta-analysis.
RESULTS: Ischemic cardiac etiology was present in 32% (95% CI, 24-47) of TAH
CONCLUSIONS: Patients on Bi-HVAD support were more likely to be able to be discharged home on support and had similar overall mortality to TAH, albeit with much longer duration of support.
Volume
9
Issue
2
First Page
69
Last Page
80
ISSN
2225-319X
Published In/Presented At
Maynes, E. J., O'Malley, T. J., Luc, J. G. Y., Weber, M. P., Horan, D. P., Choi, J. H., Patel, S., Abbas Rizvi, S. S., Morris, R. J., Entwistle, J. W., Massey, H. T., & Tchantchaleishvili, V. (2020). Comparison of SynCardia total artificial heart and HeartWare HVAD biventricular support for management of biventricular heart failure: a systematic review and meta-analysis. Annals of cardiothoracic surgery, 9(2), 69–80. https://doi.org/10.21037/acs.2020.03.07
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
32309154
Department(s)
Administration and Leadership
Document Type
Article